Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2009-02-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10549-009-0351-zPMID 19241156
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stromal gene expression predicts clinical outcome in breast cancer

  2008cited by this paper
• Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast

  2008cited by this paper
• The fibromatosis signature defines a robust stromal response in breast carcinoma

  2008cited by this paper
• Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome

  2008cited by this paper
• Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells

  2007cited by this paper
• Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse

  2007cited by this paper
• Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

  2007cited by this paper
• Study of matrix metalloproteinases and their inhibitors in breast cancer

  2007influential reference
• Breast-cancer stromal cells with TP53 mutations and nodal metastases.

  2007cited by this paper
• Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma.

  2007cited by this paper
• A Mouse Stromal Response to Tumor Invasion Predicts Prostate and Breast Cancer Patient Survival

  2006cited by this paper
• Tumor stroma and regulation of cancer development.

  2006cited by this paper
• Targeting Matrilysin and Its Impact on Tumor Growth In vivo: The Potential Implications in Breast Cancer Therapy

  2005cited by this paper
• Tissue inhibitor of metalloproteinases-1 in breast cancer.

  2005cited by this paper
• Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.

  2005cited by this paper
• Supplemental Data Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion

  2005cited by this paper
• Tumour-Stromal Interactions in Breast Cancer: The Role of Stroma in Tumourigenesis

  2005cited by this paper
• Tumor-stroma interactions.

  2005cited by this paper
• Determination of Stromal Signatures in Breast Carcinoma

  2005cited by this paper
• Tumour angiogenesis: vascular growth and survival

  2004cited by this paper
• Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis

  2004cited by this paper
• Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.

  2004cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

  2002cited by this paper
• Complex roles of tissue inhibitors of metalloproteinases in cancer

  2002cited by this paper
• The microenvironment of the tumour–host interface

  2001cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis.

  2001cited by this paper
• The Ets‐1 transcription factor is up‐regulated together with MMP 1 and MMP 9 in the stroma of pre‐invasive breast cancer

  2001cited by this paper
• Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention.

  1999cited by this paper
• The Matrix Metalloproteinase-9 Regulates the Insulin-like Growth Factor-triggered Autocrine Response in DU-145 Carcinoma Cells*

  1999cited by this paper
• Matrix metalloproteinases generate angiostatin: effects on neovascularization.

  1998cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Control of matrix metalloproteinase activity in cancer

  1997cited by this paper

• Impending role of inflammatory markers and their specificity and sensitivity in breast cancer patients

  2024cites this paper
• Chemokine receptors and their ligands in breast cancer: The key roles in progression and metastasis.

  2024cites this paper
• MMP-11 expression in early luminal breast cancer: associations with clinical, MRI, pathological characteristics, and disease-free survival

  2024cites this paper
• The peritumor microenvironment: physics and immunity.

  2023cites this paper
• The Functional Role of Extracellular Matrix Proteins in Cancer

  2022cites this paper
• Joint Tumor Bud–MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma

  2021cites this paper
• Cancer-Associated Fibroblasts in Breast Cancer Treatment Response and Metastasis

  2021cites this paper
• Personal Medicine and Bone Metastases: Biomarkers, Micro-RNAs and Bone Metastases

  2020cites this paper
• Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination

  2020cites this paper
• Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells

  2019cites this paper
• MMP11 expression in intratumoral inflammatory cells in breast cancer

  2019cites this paper
• Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities

  2019cites this paper
• Importancia de la investigación sobre el estroma tumoral en el cáncer de mama

  2019cites this paper
• Proteases as prognostic markers in human and canine cancers

  2017cites this paper
• Increased expression of tissue inhibitor of metalloproteinase‐1 correlates with improved outcome in canine cutaneous mast cell tumours

  2017cites this paper
• Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes

  2017cites this paper
• Predictive factors of non-sentinel axillary lymph nodes in breast cancer patients . Molecular markers of primary tumor and variability of patient ' s microenvironment

  2017cites this paper
• Number : CBC-D15-00331 R 1 Title : Expression and clinical significance of metalloproteases and their inhibitors by endothelial cells from invasive breast carcinomas

  2016cites this paper
• The role of cancer-associated fibroblasts in breast cancer pathobiology.

  2016cites this paper
• Prognostic significance of inflammatory factors expression by stroma from breast carcinomas.

  2016cites this paper
• Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and tumor expression of metalloproteases and their inhibitors in invasive breast cancer.

  2016cites this paper
• Expression and Clinical Significance of Metalloproteases and Their Inhibitors by Endothelial Cells From Invasive Breast Carcinomas.

  2016cites this paper
• Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications

  2016cites this paper
• Imunomarcação de Metaloproteinase 2 e 9 e seus respectivos Inibidores Teciduais como potenciais Indicadores Prognósticos para Mastocitomas Cutâneos Caninos

  2016cites this paper
• Matrix metalloproteinase 9 expression in canine mammary carcinomas

  2016cites this paper
• Cancer-associated fibroblasts: a multifaceted driver of breast cancer progression.

  2015cites this paper
• MMPs in Biology and Medicine

  2015cites this paper
• Expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2 in Intraepithelialand Invasive Cervical Neoplasia

  2015cites this paper
• A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer

  2015cites this paper
• Perioperative propofol-paravertebral anesthesia decreases the metastasis and progression of breast cancer

  2015cites this paper
• The source of matrix-degrading enzymes in human cancer: Problems of research reproducibility and possible solutions

  2015cites this paper
• Matrix metalloproteinases as breast cancer drivers and therapeutic targets.

  2015cites this paper
• TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group

  2014cites this paper
• Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells

  2014cites this paper
• Omic-profiling in breast cancer metastasis to bone: implications for mechanisms, biomarkers and treatment.

  2014cites this paper
• Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis

  2014cites this paper
• Expression patterns of stromal MMP‐2 and tumoural MMP‐2 and ‐9 are significant prognostic factors in invasive ductal carcinoma of the breast

  2014cites this paper
• Universitet TIMP-1 and responsiveness to gemcitabine in advanced breast cancer

  2014cites this paper
• Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas

  2013cites this paper
• Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph node.

  2013cites this paper
• Investigation of the Functional Significance of MMP-8 in Breast Myoepithelial Cells.

  2013cites this paper
• Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis

  2013cites this paper
• Interaction between tumour and microenvironment - molecular mechanisms of cell migration in canine tumours

  2013cites this paper
• Toll-like Receptor-4 Expression by Stromal Fibroblasts Is Associated With Poor Prognosis in Colorectal Cancer

  2013cites this paper
• Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.

  2013cites this paper
• Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets

  2013influential citation
• Clinical Relevance of Matrix Metalloproteases and their Inhibitors in Breast Cancer

  2013influential citation
• Clinical Relevance of MMP and TIMP Measurements in Cancer Tissue

  2012cites this paper
• Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome.

  2012cites this paper
• Diagnostic and Prognostic Relevance of MMP-11 Expression in the Stromal Fibroblast-Like Cells Adjacent to Invasive Ductal Carcinoma of the Breast

  2012cites this paper
• Impact of CD68/(CD3+CD20) Ratio at the Invasive Front of Primary Tumors on Distant Metastasis Development in Breast Cancer

  2012cites this paper
• [Role of metalloproteinases and their inhibitors in tumors].

  2012cites this paper
• ROL DE LAS METALOPROTEINASAS Y SUS INHIBIDORES EN PATOLOGÍA TUMORAL

  2012cites this paper
• Experimental Approaches for Understanding the Role of Matrix Metalloproteinases in Cancer Invasion

  2012cites this paper
• Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer

  2011cites this paper
• Serum TIMP-1 predicts survival outcomes of invasive breast carcinoma patients: a meta-analysis.

  2011cites this paper
• Matrix metalloproteinases and their inhibitors in canine mammary tumors

  2011cites this paper
• Novel Insights Into the Role of Inflammation in Promoting Breast Cancer Development

  2011cites this paper
• Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer

  2010cites this paper
• Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer

  2010influential citation
• Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis

  2010cites this paper
• Strong cytoplasmic expression of COX2 at the invasive fronts of gallbladder cancer is associated with a poor prognosis

  2010cites this paper
• Prognostic Value of Matrix Metalloproteinase 9 Expression in Breast Cancer Patients : A Meta-analysis

  year unknowncites this paper
• gela-Matrix metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factors and patient outcome

  year unknowncites this paper